226 related articles for article (PubMed ID: 21139074)
21. Phosphorylation of C3a receptor at multiple sites mediates desensitization, β-arrestin-2 recruitment and inhibition of NF-κB activity in mast cells.
Gupta K; Subramanian H; Klos A; Ali H
PLoS One; 2012; 7(10):e46369. PubMed ID: 23077507
[TBL] [Abstract][Full Text] [Related]
22. Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis.
Hunton DL; Barnes WG; Kim J; Ren XR; Violin JD; Reiter E; Milligan G; Patel DD; Lefkowitz RJ
Mol Pharmacol; 2005 Apr; 67(4):1229-36. PubMed ID: 15635042
[TBL] [Abstract][Full Text] [Related]
23. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
[TBL] [Abstract][Full Text] [Related]
24. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2.
Zhao M; Wimmer A; Trieu K; Discipio RG; Schraufstatter IU
J Biol Chem; 2004 Nov; 279(47):49259-67. PubMed ID: 15364949
[TBL] [Abstract][Full Text] [Related]
25. beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1.
Usui I; Imamura T; Huang J; Satoh H; Shenoy SK; Lefkowitz RJ; Hupfeld CJ; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(20):8929-37. PubMed ID: 15456867
[TBL] [Abstract][Full Text] [Related]
26. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ
Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355
[TBL] [Abstract][Full Text] [Related]
27. Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR).
Xiao K; Sun J; Kim J; Rajagopal S; Zhai B; Villén J; Haas W; Kovacs JJ; Shukla AK; Hara MR; Hernandez M; Lachmann A; Zhao S; Lin Y; Cheng Y; Mizuno K; Ma'ayan A; Gygi SP; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15299-304. PubMed ID: 20686112
[TBL] [Abstract][Full Text] [Related]
28. β-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation.
Boutin A; Eliseeva E; Gershengorn MC; Neumann S
FASEB J; 2014 Aug; 28(8):3446-55. PubMed ID: 24723693
[TBL] [Abstract][Full Text] [Related]
29. Interaction of profilin-1 and F-actin via a β-arrestin-1/JNK signaling pathway involved in prostaglandin E(2)-induced human mesenchymal stem cells migration and proliferation.
Yun SP; Ryu JM; Jang MW; Han HJ
J Cell Physiol; 2011 Feb; 226(2):559-71. PubMed ID: 20717968
[TBL] [Abstract][Full Text] [Related]
30. Prolonged stimulation of μ-opioid receptors produces β-arrestin-2-mediated heterologous desensitization of α(2)-adrenoceptor function in locus ceruleus neurons.
Dang VC; Chieng BC; Christie MJ
Mol Pharmacol; 2012 Sep; 82(3):473-80. PubMed ID: 22689562
[TBL] [Abstract][Full Text] [Related]
31. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
[TBL] [Abstract][Full Text] [Related]
32. KISS1R signals independently of Gαq/11 and triggers LH secretion via the β-arrestin pathway in the male mouse.
Ahow M; Min L; Pampillo M; Nash C; Wen J; Soltis K; Carroll RS; Glidewell-Kenney CA; Mellon PL; Bhattacharya M; Tobet SA; Kaiser UB; Babwah AV
Endocrinology; 2014 Nov; 155(11):4433-46. PubMed ID: 25147978
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase.
Freedman NJ; Liggett SB; Drachman DE; Pei G; Caron MG; Lefkowitz RJ
J Biol Chem; 1995 Jul; 270(30):17953-61. PubMed ID: 7629102
[TBL] [Abstract][Full Text] [Related]
34. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574
[TBL] [Abstract][Full Text] [Related]
35. Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization.
Ménard L; Ferguson SS; Zhang J; Lin FT; Lefkowitz RJ; Caron MG; Barak LS
Mol Pharmacol; 1997 May; 51(5):800-8. PubMed ID: 9145918
[TBL] [Abstract][Full Text] [Related]
36. Myometrial contractility influences oxytocin receptor (OXTR) expression in term trophoblast cells obtained from the maternal surface of the human placenta.
Szukiewicz D; Bilska A; Mittal TK; Stangret A; Wejman J; Szewczyk G; Pyzlak M; Zamlynski J
BMC Pregnancy Childbirth; 2015 Sep; 15():220. PubMed ID: 26377392
[TBL] [Abstract][Full Text] [Related]
37. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*.
Oakley RH; Laporte SA; Holt JA; Barak LS; Caron MG
J Biol Chem; 2001 Jun; 276(22):19452-60. PubMed ID: 11279203
[TBL] [Abstract][Full Text] [Related]
38. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
[TBL] [Abstract][Full Text] [Related]
39. Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling.
Kim J; Ahn S; Ren XR; Whalen EJ; Reiter E; Wei H; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1442-7. PubMed ID: 15671181
[TBL] [Abstract][Full Text] [Related]
40. Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2.
Hoffmann C; Ziegler N; Reiner S; Krasel C; Lohse MJ
J Biol Chem; 2008 Nov; 283(45):30933-41. PubMed ID: 18703513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
